Allergen-specific immunotherapy: history, methods and new options
https://doi.org/10.21518/2079-701X-2013-3-2-10-19
Abstract
Today, allergy can easily be called a disease of the XXI century. Patients are increasingly complaining about various forms of allergy. Allergy symptoms are varied and diverse, as are the ways of treatment of allergic diseases. According to the statistics from the Institute of Immunology of FMBA, Russia, from 17 to 35% of Russia's population are suffering from various forms of allergy. According to the official statistics, however, the figure varies between 1 and 1.5% [1, 2, 3]. The GA2LEN study held in 2009 found that of the total 550 respondents, 39 had bronchial asthma, while another 84 people could have asthma. Sinusitis was found in 121 people, and sinusitis concurrent with asthma in 56 [2, 3, 4]. Late diagnosis, treatment and prevention of allergic diseases, therefore, remains a major challenge.
About the Authors
O. M. Kurbacheva
Federal Medical and Biological Agency of Russia (FMBA), Moscow
Russian Federation
Russian Federation
K. S. Pavlova
Federal Medical and Biological Agency of Russia (FMBA), Moscow
Russian Federation
Russian Federation
I. E. Kozulina
Federal Medical and Biological Agency of Russia (FMBA), Moscow
Russian Federation
Russian Federation
References
1. Ильина Н.И. Актуальное интервью. Эффективная фармакотерапия // Аллергология и иммунология. 2012. №2.
2. Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its impact on asthma ( ARIA) 2008 // Allergy 2008.
3. Bauchau V., Durham S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe // Eur. Resp. J. 2004. №24(5). '
4. Ильина Н.И., Курбачева О.М., Павлова К.С., Ильина Е.В. Скрининговое эпидемиологическое исследование (GA2LEN) по выявлению аллергических заболеваний и заболеваний органов дыхания в России // Российский аллергологический журнал. 2009. №3. Вып. 1. С. 486-487.
5. Курбачева О.М. Клинические, патогенетические и экономические аспекты применения аллергенспецифической иммунотерапии. Автореф. дисс. ... д-ра мед. наук. М., 2007.
6. Павлова К.С. Клинико-экономический анализ лечения поллинозов. Дисс. ... канд. мед. наук. М., 2004.
7. Аллергология и иммунология. Национальное руководство. М.: Гэотар-Медиа, 2009.
8. Acdis M., Schvidt-Weber C. et al. Mechanism of allergen immunotherapy // Allergy Clin. Immunol. Int. J. World Allergy org. 2004. Vol. 16. №2.
9. Гущин И.С., Курбачева О.М. Аллергия и аллерген-специфическая иммунотерапия. М.: Фармарус Принт Медиа, 2010.
10. Павлова К.С., Курбачева О.М. Патогенетическая терапия аллергических заболеваний: возможности АСИТ в России. Эффективная фармакотерапия // Аллергология и иммунология. 2012. №2.
11. Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy^ therapeutic vaccines for allergic deseases. A WHO position paper // J. Allergy clin. Immunol. 1998. Vol. 192. №4.
12. Bergmann K.C. From grass pollen exposure to allergen immunotherapy^ what have we learned? // Clin. EXP. Allergy Rev. 2008.
13. Оралейр: монография. М.: ООО «Сталлержен Восток».
14. Horak F., Zeiglmayer P. et al. Early onset of action of a 5-grass-pollen 300 IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber // J. Allergy Clin. Immunol. 2009.
15. Didier A., Malling H.J., Worm M. et al. Optimal dose, efficacy and safety of jnce-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis // J. Allergy Clin. Immunol. 2007.
16. Wahn U., Tabar A., Kuna P. et al. Efficacy and safety of 5-grass-pollen 300 IR sublingual immunotherapy tablets in pediatric allergic rhinoconjuctivitis // J. Allergy Clin. Immunol. 2009.
Review
For citations:
Kurbacheva OM, Pavlova KS, Kozulina IE. Allergen-specific immunotherapy: history, methods and new options. Meditsinskiy sovet = Medical Council. 2013;(3-2):10-19. (In Russ.) https://doi.org/10.21518/2079-701X-2013-3-2-10-19
Views:
952
Email this article 